ONCY Oncolytics Biotech, Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oncolytics Biotech, Inc. market cap is $88.24M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Oncolytics Biotech, Inc. 52 week high is $3.39 as of May 11, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oncolytics Biotech, Inc. 52 week low is $0.883 as of May 11, 2024.

Oncolytics Biotech, Inc. stock price today is $1.17.

Oncolytics Biotech, Inc. stock price yesterday was $1.24.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oncolytics Biotech, Inc.’s P/E ratio is -3.91.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oncolytics Biotech, Inc. P/B ratio is 5.1988.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Oncolytics Biotech, Inc.'s EBITDA is -2.82.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oncolytics Biotech, Inc. 50-day moving average is $1.08.

Oncolytics Biotech, Inc. has 27 employees.